Paper9712903
High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages.
Veillette A and 2 others. J Biol Chem, 1998. Cited by 203 papers, by iCite.
Cite this record
ConductScience Library. High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages. Papers, record 9712903. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9712903
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages.
- PubMed
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Differentiation | Major topic |
| Macrophages, Peritoneal | Major topic |
| Membrane Glycoproteins | Major topic |
| Neural Cell Adhesion Molecule L1 | Major topic |
| Neural Cell Adhesion Molecules | Major topic |
| Protein Tyrosine Phosphatases | Major topic |
| Receptors, Immunologic | Major topic |
| Alternative Splicing | |
| Amino Acid Sequence | |
| Animals | |
| Bone Marrow Cells | |
| Cell Line | |
| Cloning, Molecular | |
| DNA, Complementary | |
| Glycosylation | |
| Intracellular Signaling Peptides and Proteins | |
| Mice | |
| Mice, Inbred C57BL | |
| Molecular Sequence Data | |
| Phosphorylation | |
| Protein Binding | |
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | |
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | |
| SH2 Domain-Containing Protein Tyrosine Phosphatases | |
| Sequence Homology, Amino Acid | |
| Tyrosine |
Source PubMed
Cited by92
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 203 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42279389 | Myeloid Malignancies Beyond the Cell: Targeting the Tumour Microenvironment with Next-Generation Immunotherapies. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42279389 | PubMed |
| 41614207 | Tumor-Associated Macrophages as Therapeutic Targets: Deciphering Interaction Networks and Advancing Clinical Translation. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/41614207 | PubMed |
| 41410050 | More Than a Cleanup Crew: The Expanding Biology of Efferocytosis. | Arterioscler Thromb Vasc Biol | 2026 | https://conductscience.org/library/papers/41410050 | PubMed |
| 41360986 | Targeting phagocytosis checkpoints for cancer immunotherapy. | Nat Rev Cancer | 2026 | https://conductscience.org/library/papers/41360986 | PubMed |
| 41217108 | Phospho-activated non-muscle myosin IIA heavy chain supports different mechanisms of virus uptake. | J Virol | 2025 | https://conductscience.org/library/papers/41217108 | PubMed |
| 41100219 | CD47 inhibits phagocytosis through Vav dephosphorylation. | J Cell Biol | 2025 | https://conductscience.org/library/papers/41100219 | PubMed |
| 40853495 | Targeting the CD47-SIRPalpha checkpoint in multiple myeloma. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40853495 | PubMed |
| 40763927 | Functional Differences Between SIRPα Splice Isoforms. | Genes Cells | 2025 | https://conductscience.org/library/papers/40763927 | PubMed |
| 40425821 | Inhibitory pattern recognition receptors: lessons from LAIR1. | Nat Rev Immunol | 2025 | https://conductscience.org/library/papers/40425821 | PubMed |
| 40356928 | Revealing the mechanisms and therapeutic potential of immune checkpoint proteins across diverse protein families. | Front Immunol | 2025 | https://conductscience.org/library/papers/40356928 | PubMed |
| 40177549 | Beyond cancer: The potential application of CD47-based therapy in non-cancer diseases. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/40177549 | PubMed |
| 39415597 | The Physiological and Therapeutic Role of CD47 in Macrophage Function and Cancer. | Immunol Invest | 2025 | https://conductscience.org/library/papers/39415597 | PubMed |
| 39257438 | A pan-allelic human SIRPα-blocking antibody, ES004-B5, promotes tumor killing by enhancing macrophage phagocytosis and subsequently inducing an effective T-cell response. | Antib Ther | 2024 | https://conductscience.org/library/papers/39257438 | PubMed |
| 39007135 | The dualistic role of Lyn tyrosine kinase in immune cell signaling: implications for systemic lupus erythematosus. | Front Immunol | 2024 | https://conductscience.org/library/papers/39007135 | PubMed |
| 38920727 | A Perspective on the CD47-SIRPA Axis in High-Risk Neuroblastoma. | Curr Oncol | 2024 | https://conductscience.org/library/papers/38920727 | PubMed |
| 38786045 | Glioblastoma Phagocytic Cell Death: Balancing the Opportunities for Therapeutic Manipulation. | Cells | 2024 | https://conductscience.org/library/papers/38786045 | PubMed |
| 38773064 | Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/38773064 | PubMed |
| 38319147 | Discovery and Preclinical Activity of BMS-986351, an Antibody to SIRPα That Enhances Macrophage-mediated Tumor Phagocytosis When Combined with Opsonizing Antibodies. | Cancer Res Commun | 2024 | https://conductscience.org/library/papers/38319147 | PubMed |
| 37762478 | The Cytotoxic Effect of Septic Plasma on Healthy RBCs: Is Eryptosis a New Mechanism for Sepsis? | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37762478 | PubMed |
| 37068796 | BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells. | J Immunother Cancer | 2023 | https://conductscience.org/library/papers/37068796 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PTPN6 | 5777 | Swiss-Prot's references | https://conductscience.org/library/genes/5777 | NCBI Gene |
| PTPN11 | 5781 | PubTator's text mining | https://conductscience.org/library/genes/5781 | NCBI Gene |
| SIRPA | 140885 | PubTator's text mining | https://conductscience.org/library/genes/140885 | NCBI Gene |
Data2
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9712903
GET https://conductscience.org/api/papers/v1/9712903/cited_by?page=2